MICHAEL STORMONT: Open Payments
NPI 1811221153 · GALION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 33 payments from 9 companies in 2025. Trend: 2023 $484 · 2024 $490 · 2025 $626
Food & beverage: $610Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $291 |
| Teleflex LLC | 1 | $116 |
| Indivior Inc. | 3 | $70 |
| Abbott Laboratories | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Braeburn Inc. | 1 | $15 |
Products named: VRAYLAR, UBRELVY, UROLIFT, SUBLOCADE, FREESTYLE LIBRE 2, REXULTI, Kerendia, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
